Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
CLDX
Celldex Therapeutics, Inc.
NASDAQ · In Vitro & In Vivo Diagnostic Substances
Last close
$32.41
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
In Vitro & In Vivo Diagnostic Substances
Market cap
$2.55B
RECENT INSIDER TRADES
2025-12-08
· Jimenez Freddy A.
(SVP & GENERAL COUNSEL)
· SELL
2025-11-17
· Wright Richard M.
(Other)
· SELL
2025-08-15
· Jimenez Freddy A.
(SVP & GENERAL COUNSEL)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
266
Shares held
94,221,361
Value
$3.28B
Percent of shares outstanding
119.98%
As of quarter end
2026-06-30
RECENT NEWS
Celldex Therapeutics: Trying To Put Its Troubled History Behind It
Celldex Therapeutics Leads Guggenheim’s Biotechnology Rankings
Celldex Therapeutics, Inc. (CLDX) Discusses Positive Phase 3 Results for Barzolvolimab in Chronic Spontaneous Urticaria - Slideshow
Why is Celldex Therapeutics stock sliding today?
CLDX: Celldex reports positive Phase 3 data
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS